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Work Stress and Metabolic and Hemostatic Risk Factors
TANJA G. M. VRIJKOTTE, MSC, LORENZ J. P. VAN DOORNEN, PHD, AND ECO J. C. DE GEUS, PHD
Objective: A high level of work stress has been associated with cardiovascular disease. However, the pathophysi-
ological mechanisms underlying this association remain unclear. This study examined the effect of work stress on
a cluster of metabolic and hemostatic risk factors. Methods: Blood was collected three times, on the first, third, and
fifth day of a work week, from 124 middle-aged, white-collar workers. Metabolic measures were insulin, glucose,
triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and total cholesterol. He-
mostatic measures were fibrinogen, tissue-type plasminogen activator activity, tissue-type plasminogen activator
antigen, and type 1 plasminogen activator inhibitor antigen. Chronic work stress was defined according to Siegrist’s
model as 1) a combination of high effort and low reward at work (effort-reward imbalance) or 2) high overcommit-
ment (an exhaustive work-related coping style). Results: Overcommitment, but not imbalance or the imbalance-
overcommitment interaction, was associated with an impaired fibrinolytic system, as reflected in decreased
tissue-type plasminogen activator activity levels and increased type 1 plasminogen activator inhibitor antigen levels
on all three measurement occasions. After controlling for body mass index, total cholesterol, triglycerides, high-
density lipoprotein/low-density lipoprotein cholesterol ratio, glucose, and insulin, the relation between overcom-
mitment and the fibrinolytic factors was attenuated but remained significant. Conclusions: The results suggest that
individuals with an exhaustive coping style at work have an impaired fibrinolytic capacity that is possibly due to
the effects of chronic stress on insulin resistance. Key words: fibrinolysis, insulin resistance syndrome, chronic
stress, overcommitment.
BMI 5 body mass index; HDL 5 high-density lipopro-
tein; IRS 5 insulin resistance syndrome; LDL 5 low-
density lipoprotein; PAI-1 5 type 1 plasminogen acti-
vator inhibitor; TC 5 total cholesterol; TG 5
triglyceride; tPA 5 tissue-type plasminogen activator.
INTRODUCTION
Recent prospective studies (1, 2) have shown that
the risk of coronary disease is associated with various
indices of work stress (eg, high job demands, low re-
sources, low income, and low status control). Despite
this epidemiological evidence, definite knowledge
about the pathophysiological link between work stress
and heart disease is still lacking, although several
mechanisms have been proposed (3, 4). Experimental
animal models and human studies have shown that
indices of psychosocial stress are associated with glu-
cose intolerance, hyperinsulinemia, dyslipidemia, and
hypertension (5–9). These associations are thought to
derive from the hormonal and cardiovascular re-
sponses to repeated activation of the autonomic ner-
vous system (9). Although these metabolic factors in-
dependently increase the risk for cardiovascular
disease, they tend to cluster in certain individuals.
This aggregation of metabolic risk factors, first de-
scribed by Reaven (10), is called the insulin resistance
syndrome, or IRS, because resistance to insulin-stim-
ulated glucose uptake has been postulated to be the
primary defect (11, 12).
Apart from metabolic risk factors, the risk of devel-
oping atherosclerosis or atherothrombosis is influ-
enced by the balance between coagulation and fibrino-
lysis (12, 13). Elevated levels of plasma fibrinogen
predict cardiovascular disease (14, 15). tPA activity
converts plasminogen into active plasmin, which
breaks down intravascular fibrin clots. PAI-1 regulates
the concentration of tPA activity by continuously
forming inactive tPA–PAI-1 complexes in a well-char-
acterized bimolecular reaction (16). The active part of
tPA and PAI-1 (activity) can be measured, as can total
levels of tPA and PAI-1 (antigen) that include PAI-1
and tPA in their complexed form (16). tPA antigen
seems to be positively associated with risk of myocar-
dial infarction (17, 18). Although less consistently,
increased PAI-1 and low tPA activity have also been
associated with an increased risk of myocardial infarc-
tion (15, 18–20) as well as thrombosis (13, 21). Many
studies have demonstrated that an imbalance in coag-
ulation and fibrinolysis is associated with insulin re-
sistance (22, 23). Insulin may exert a direct action on
the synthesis of PAI-1 by endothelial cells or hepato-
cytes or indirectly by plasma TG levels (24, 25) or
nonesterified fatty acids (26). Therefore, deficient fi-
brinolysis is now regarded to be part of IRS (22, 23).
Like the metabolic aspects of IRS, fibrinogen, tPA, and
PAI-1 are influenced by acute psychological stress
(27–29).
Specific studies on the effects of chronic work stress
on the variables of IRS are few and inconsistent.
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Schnall et al. (30), in a review of the literature, found
little evidence for effects of job strain on the lipid
profile. In a recent study, however, low decision lati-
tude at work was found to be associated with low HDL
cholesterol levels (31). Markowe et al. (32) and Siegrist
et al. (33) found a positive association between job
stress scores and fibrinogen concentration, but two
recent studies failed to replicate this effect (34, 35).
Ishizaki et al. (36) showed that high job demands were
related to decreased tPA activity, independently of the
traditional risk factors. Two further studies reported
an association between vital exhaustion, a mood state
hypothesized to derive from the reaction to chronic
work stress (37), and impaired fibrinolysis (38, 39).
Most of the previous studies used heterogenous pop-
ulations, which makes it difficult to separate effects of
socioeconomic status differences from those of work
stress. Also, these studies assessed the effects of work
stress on subsets of the metabolic and hemostatic IRS
parameters rather than on the full cluster.
The study described here examined whether
chronic work stress is associated with fibrinogen and
the full cluster of metabolic and fibrinolytic factors of
IRS in a group of middle aged, male, white-collar
workers. Chronic work stress was assessed by a ques-
tionnaire based on Siegrist’s effort-reward imbalance
model (40). This model has been shown to predict
cardiovascular disease or shifts in cardiovascular dis-
ease risk parameters in several studies (1, 34, 40, 41).
The model defines chronically stressful experience at
work in terms of a mismatch between high effort spent
and low reward received in occupational life. Two
sources of effort at work are explicitly distinguished:
an extrinsic source, the demands on the job (situa-
tional), and an intrinsic source, a personal pattern of
coping with work demands (personal). The model of
effort-reward imbalance states that lack of reciprocity
between costs and gains defines a state of emotional
distress with special propensity to autonomic arousal
and neuroendocrine stress responses, resulting in
higher cardiovascular risk (42). This lack of reciproc-
ity, or mismatch, is expressed by two summary mea-
sures of work stress: 1) by calculating the ratio between
extrinsic effort and rewards (imbalance) and 2) by the
sum score of the intrinsic effort component (overcom-
mitment). This last component is by itself a mismatch
score because those individuals who score high are
characterized by excessive overcommitment. They
tend to spend an inadequate amount of effort that is
not met by the externally defined rewards.
Several studies have shown intraweek mood changes
and fluctuations in daily stress during the work week
(43–46), with negative mood and stress usually lower in
the weekend compared with the work week. There is
abundant evidence of effects of daily mood and stress on
catecholamines (45) and cortisol (46), which are both
important determinants of many of the risk parameters
assessed in our study (6, 27, 28, 47–49). There are cur-
rently no studies directly addressing intraweek changes
in hemostatic or metabolic blood variables. It is also
unknown whether such short-term fluctuations are influ-
enced by the level of overcommitment or effort-reward
imbalance. Apart from assessing the main effects of ef-
fort-reward imbalance and overcommitment on meta-
bolic and hemostatic risk factors, our study explored the
effects of imbalance and overcommitment on the
changes in these variables in the course of a single work
week.
MATERIALS AND METHODS
Subjects
The study population consisted of middle-aged (range, 35–55
years; mean 6 SD, 45.2 6 5.3 years), white-collar workers, all work-
ing at the same large computer company. All subjects, who worked
in departments where mainly sitting work was done, were consid-
ered eligible if they were between 35 and 55 years of age. Eight
hundred twenty subjects received the effort-reward imbalance work
stress questionnaire (see below). Four hundred sixty subjects (57%)
returned the questionnaire, and from this group, 300 were willing to
participate in the study. Of these 300 subjects, 148 subjects (126
men, 22 women), working in departments where subjects showed a
large variation in work stress scores, were selected for blood sam-
pling. The mean overcommitment score for the selected group was
11.0 6 4.2, which was not significantly different from that of the
nonselected group (11.2 6 4.7). Also, the percentage of subjects with
imbalance between effort and reward was not significantly different
between the selected and nonselected groups (20.9% and 18.6%,
respectively). The analyses in this study were restricted to men
because the number of women in the selected group, as a conse-
quence of the male-female distribution in the company, was too
small for the planned statistical analyses.
Of the 126 men, two subjects were excluded because of a glucose
value .7.8 mmol/liter, which is an indicator of diabetes mellitus
according to World Health Organization criteria. None of the sub-
jects received treatment for hypertension, hyperlipidemia, or diabe-
tes mellitus, and all subjects were free of overt cardiovascular dis-
ease. The study protocol was approved by the ethics committee of
Vrije Universiteit, and all subjects gave written consent before en-
trance into the study.
Measures
Work Stress. A Dutch version of the effort-reward imbalance
questionnaire developed by Siegrist was used to measure perceived
chronic work stress. The underlying model defines chronically
stressful experience at work in terms of mismatch between high
effort spent and low reward received in occupational life. The model
defines two sources of high effort at work: 1) the demands of the job
(extrinsic effort) and 2) the motivation and ability of the individual
worker to cope with a demanding situation (intrinsic effort). Extrin-
sic effort is measured by six items, and occupational reward is
measured by 12 items that refer to esteem reward, monetary gratifi-
cation, and status control. Intrinsic effort was assessed by 29 items
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that refer to four factors: 1) need for approval, 2) competitiveness, 3)
impatience and a disproportionate level of irritability, and 4) inabil-
ity to withdraw from work obligations. The total sum of the four
subscales defines the sum score of intrinsic effort, which is also
called overcommitment.
The analysis was based on two summary measures, imbalance
and overcommitment. Imbalance is the ratio between extrinsic effort
and reward multiplied by 2. An imbalance .1 means high chronic
work stress, and an imbalance #1 means low chronic work stress (4).
Overcommitment is the sum score of intrinsic effort. A value in the
upper tertile (high overcommitment) indicates a critically high level
associated with adverse health effects (50, 51). The lower two tertiles
comprised the low overcommitment group. Reliabilities (Cronbach’s
a) for the overcommitment score as well as for the scores for the
reward and extrinsic effort subscales were 0.79, 0.75, and 0.66,
respectively. Subjects were classified on the basis of scores for
imbalance and overcommitment into high and low groups.
Blood Variables. Blood was collected by venipuncture and sam-
pled in six different tubes in the following order: serum (3 ml),
serum with cloth activator (5 ml), stabilyte (5 ml), citrate (5 ml),
ethylenediaminetetraacetic acid (3 ml), and NaF (2 ml). All tubes
were centrifuged at 2000g for 20 minutes at 4°C. For determination
of TC, TGs, and HDL, the tube containing serum with cloth activator
was used. Lipid determinations were performed on the same day
using the Vitros 250 clinical chemistry analyzer (Johnson & Johnson,
Rochester, NY) with Vitros clinical chemistry slides for TC and TGs.
HDL was measured after a precipitation step with HDL cholesterol
precipitant (Boehringer Mannheim, Mannheim, Germany). LDL was
calculated using the formula of Friedewald (52). Fasting insulin was
measured with an immunoradiometric assay kit (Medgenix Diagnos-
tics, Fleurus, Belgium) by means of the serum tube. Aliquots of
serum were stored at 220°C, and all samples were analyzed simul-
taneously; no sample was stored for .5 months.
Fasting glucose was measured in plasma (NaF tube). Aliquots of
plasma were stored at 220°C, and the glucose concentration was
determined within 5 days using the Hitachi 747 automatic analyzer
by the hexokinase method (Hitachi, Ltd., Tokyo, Japan).
Blood collection and handling of the hemostatic variables were
performed according to the European Concerted Action on Thrombosis
assay procedure (53). Stabilyte blood was collected for the determina-
tion of tPA activity, and citrated blood was collected for the determi-
nation of PAI-1 antigen, tPA antigen, and fibrinogen. Immediately after
collection, the tubes were placed in melting ice and centrifuged within
60 minutes. Aliquots of plasma were snap-frozen immediately and
stored at 280°C. All samples were analyzed simultaneously in a single
batch. No sample was stored for .8 months. tPA activity was measured
using the biofunctional immunosorbent assay Chromolize tPA
(Biopool, Umeå, Sweden). PAI-1 antigen was measured using the In-
notest PAI-1 immunoassay (Innogenetics, Zwijndrecht, Belgium) (54).
tPA antigen was measured using the enzyme immunoassay Imulyse
tPA (Biopool, Uneå, Sweden). No effort was made to separately assess
PAI-1 activity because it has been reported to correlate very highly with
PAI-antigen (16). Fibrinogen was measured using the STA coagulation
analyzer (STAG-O, Asnie`res, France) and the STA fibrinogen kit
(Boehringer Mannheim, Mannheim, Germany). The intraassay and in-
terassay coefficients of variation were ,5.0% and ,7.0% for fasting
insulin, ,4.0% and ,6.0% for TC, ,3.5% and ,5.0% for HDL, ,3.0%
and ,5.0% for TGs, ,7.5% and ,10% for tPA activity, ,10% and
,10% for PAI-1, ,10% and ,12% for tPA antigen, and ,5% and
,7% for fibrinogen, respectively.
Behavioral Factors. It is well known that age, smoking habits,
alcohol consumption, physical activity at leisure, and education
level may influence metabolic factors. These confounders were as-
sessed by a questionnaire. Smoking status was measured on a four-
point scale with the following ranking: 1) nonsmoker, 2) former
smoker, 3) smoking several times a week, and 4) smoking several
times a day. The seven-point scale for measuring educational level
ranged from primary school to university level. Physical activity was
assessed by asking the following question: “How many times a week
do you exercise till sweating in your leisure time?” Answer ranged
from 0 (zero times per week) to 4 (four or more times per week). With
regard to alcohol consumption, subjects were categorized into four
groups: 1) ,6 glasses per week, 2) 6 to 10 glasses per week, 3) 11–20
glasses per week, and 4) .20 glasses per week.
Procedure
Blood samples were obtained from each subject at the workplace
on Monday, Wednesday, and Friday. This was done between 8:00
and 9:30 AM to control for circadian variations (55). Subjects were
asked to fast and to refrain from use of alcohol, coffee, and tea after
11:00 PM the preceding night. All samples were obtained with the
subject seated after the subject had rested for at least 15 minutes.
Body weight and length were measured without shoes to calculate
BMI (in kg/m2).
Data Analysis
The following variables were log transformed before statistical
analysis to make the distributions more symmetrical: insulin, TGs,
tPA activity, fibrinogen, and PAI-1. Mean values presented were
transformed back into the original scale. Differences between the
groups with respect to age, BMI, smoking habits, alcohol consump-
tion, and physical activity were tested by one-way analysis of vari-
ance. To test for intraweek effects and differences between the
groups, a general linear models procedure was used. TC, LDL/HDL
ratio, TGs, insulin, glucose, fibrinogen, tPA antigen, tPA activity,
and PAI-1 were analyzed as dependent variables, with day as a
within-subject factor and overcommitment and imbalance as be-
tween-subject factors. When overall intraweek effects, group effects,
or interactions were found, univariate tests were performed to iden-
tify the individual variables that were responsible for the effects.
p values were adjusted for multiple comparisons with the Holm
simultaneous testing procedure as described by Aickin and Gensler
(56). Roy-Bargman stepdown F tests were used to evaluate the inde-
pendent contribution of the metabolic and hemostatic factors to
work stress. Statistical tests were performed using SPSS, version 7.5
for Windows, and statistical significance was defined as p , .05.
RESULTS
Intraweek Effects
Table 1 shows mean values for the metabolic and
hemostatic factors on Monday, Wednesday, and Fri-
day for the total group.
Intraweek (day) effects were analyzed by multivar-
iate analysis (general linear models procedure) with
the values on Monday, Wednesday, and Friday as re-
peated measurements. This analysis showed a signifi-
cant intraweek effect (F 5 4.457, p 5 .000). Univariate
analyses showed that glucose and TC were responsible
for this effect. Glucose levels were significantly higher
on Monday than on Wednesday and Friday (F 5 22.64,
p 5 .000). For TC, a significantly higher value was
T. G. M. VRIJKOTTE et al.
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found on Wednesday than on Monday and Friday (F 5
9.62, p 5 .000). The other variables showed no in-
traweek effect (Table 1). Overall, the retest correlations
(reliability) for Monday-Wednesday, Wednesday-Fri-
day, and Monday-Friday were all highly significant
and ranged from 0.67 for tPA activity to 0.95 for LDL/
HDL ratio.
Interrelationship of the Blood Parameters
Significant intercorrelations between the metabolic
and hemostatic risk factors are shown in Table 2.
These correlations were computed on the mean values
of all variables across Monday, Wednesday, and Fri-
day.
The parameters considered to be part of IRS showed
a systematic pattern of intercorrelations (Table 2, lower
left triangle). Fibrinogen, usually not considered to be
part of IRS, was not systematically related to the pa-
rameters of IRS. The correlation of insulin with the
fibrinolytic variables was higher than with the meta-
bolic variables. BMI was correlated with all variables
except TC and fibrinogen. This testifies to the central
role of BMI in IRS. When BMI was partialed out, all
correlations decreased, but most remained significant
(Table 2, upper right triangle). Age was not related to
any of the variables.
Chronic Work Stress Effects
To test the effects of chronic work stress, subjects
were divided into groups on the basis of their scores
for imbalance and overcommitment. Twenty-eight
subjects (23%) experienced a mismatch between high
effort and low reward at the workplace (imbalance .
1). The other 96 subjects were classified as low imbal-
ance. Subjects in the upper tertile of overcommitment
were considered high in overcommitment, and the
other two tertiles were low in overcommitment. As
shown in Table 3, 15 subjects (12.4%) reported high
overcommitment and high imbalance, the group with
the most stressful experiences at work. Table 3 also
shows the personal characteristics and the IRS vari-
ables as a function of high and low overcommitment
and imbalance. There were no interactions or main
effects of imbalance and overcommitment on the con-
TABLE 1. Mean and (N 5 124) of Metabolic and Hemostatic Risk Factors on Monday, Wednesday, and Friday
Variable Monday Wednesday Friday p
TC (mmol/liter) 5.47 6 0.96 5.59 6 1.00 5.46 6 1.00 .000a
TGs (mmol/liter)b 1.43 (0.42–7.34) 1.57 (0.55–8.11) 1.51 (0.51–8.62) .015
HDL/LDL ratio 3.31 6 1.36 3.39 6 1.31 3.37 6 1.33 .518
Glucose (mmol/liter) 5.89 6 0.55 5.69 6 0.47 5.71 6 0.47 .000a
Insulin (mU/liter)b 6.60 (2.36–31.83) 6.49 (2.78–22.80) 6.63 (1.67–26.55) .581
PAI-1 (ng/ml)b 72.5 (11.0–287.3) 65.8 (10.4–280.5) 66.6 (10.0–272.5) .145
tPA activity (IU/ml)b 0.54 (0.03–2.34) 0.54 (0.05–2.68) 0.52 (0.07–1.61) .574
tPA antigen (ng/ml) 10.25 6 3.64 10.17 6 3.66 10.07 6 3.57 .713
Fibrinogen (g/liter)b 2.93 (1.97–5.32) 2.93 (1.71–4.71) 2.93 (1.82–4.58) .861
a Significant intraweek effect (after correction for multiple testing according to Holm’s procedure).
b Back-transformed logarithmic mean and range.
TABLE 2. Pearson Correlation Coefficients Between Metabolic and Hemostatic Factors (Mean Values of Monday, Wednesday, and
Friday) and BMI (N 5 124)a
TC TGs
HDL/LDL
Ratio
Glucose Insulin PAI-1 tPA activity tPA antigen Fibrinogen BMI
TC — 0.51 0.45 0.25 —
TGs 0.48 — 0.49 0.45 20.27 0.37 —
HDL/LDL ratio 0.44 0.54 — 0.24 0.29 —
Glucose 0.24 0.24 — 0.28 —
Insulin 0.32 0.31 0.45 — 0.37 20.34 0.35 —
PAI-1 0.55 0.36 0.38 0.59 — 20.66 0.60 —
tPA activity 20.41 20.33 20.34 20.56 20.79 — —
tPA antigen 0.46 0.37 0.35 0.50 0.69 20.40 — —
Fibrinogen 0.25 0.23 — —
BMI 0.35 0.29 0.44 0.57 0.61 20.59 0.42 —
a Only correlations at a significance level of p , .01 are presented. Upper triangle: Partial correlation coefficients with BMI partialled out.
Lower triangle: unadjusted correlation coefficients.
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founding variables (ie, age, smoking habits, alcohol
consumption, physical activity at leisure, education
level, and years working at the company). Most nota-
bly, BMI did not differ between groups.
Multivariate analysis on the metabolic and hemo-
static factors revealed no significant differences be-
tween the high and low imbalance groups. Also, im-
balance and overcommitment showed no interaction.
Thus, simultaneous manifestation of high imbalance
and high overcommitment did not show a cumulative
effect on the blood variables. Also, no interactions
between work stress measures and day of the week
were found. There was, however, a main effect of
overcommitment (F 5 2.47, p 5 .013). This multivar-
iate effect, present on all 3 days, is portrayed in Figure
1, which shows the sum of nine standardized risk
variables on Monday, Wednesday, and Friday. All
nine parameters were first standardized using a nor-
malized Z score. The summed risk score was com-
puted as the sum of these nine Z scores using the
following formula: Zglucose 1 Zinsulin 1 ZTC 1 ZTG 1
Zfibrinogen 1 ZPAI-1 1 ZtPA antigen 2 ZtPA activity 2 ZHDL.
Clearly, overcommitment by itself and not necessarily
in combination with imbalance had an effect on the
risk profile.
For optimal analysis of the overcommitment effects,
the general linear model was simplified by eliminating
imbalance as a between-subject factor. Univariate analy-
ses showed higher levels of PAI-1 (F 5 12.23, p 5 .001),
insulin (F 5 4.61, p 5 .034), and glucose (F 5 3.93,
p 5 .050) and lower levels of tPA activity (F 5 16.57, p 5
.000) in the high overcommitment group. After Holm’s
correction for simultaneous testing, only tPA activity and
PAI-1 remained different between the two groups. When
the analysis was performed with BMI in the model as a
covariate, overcommitment was still associated with tPA
activity and PAI-1 (F 5 15.94, p 5 .000 and F 5 10.852,
p 5 .001, respectively).
The results of the univariate analyses showed that
PAI-1 and tPA activity are significantly associated
with overcommitment. To evaluate whether tPA activ-
ity and PAI-1 are associated with overcommitment
independently of the metabolic risk factors, models
with TC, TGs, HDL/LDL ratio, glucose, and insulin as
covariates were fitted (Roy-Bargman stepdown F tests).
Both tPA activity and PAI-1 still predicted overcom-
mitment after this procedure (F 5 9.07, p 5 .003 and
F 5 9.81, p 5 .002 respectively). However, the corre-
lation between PAI-1 and tPA activity was very high
(20.79). Addition of either tPA activity or PAI-1 as a
further covariate rendered the association with over-
commitment nonsignificant (F 5 1.92, p 5 .17). Thus,
PAI-1 and tPA activity are both associated with over-
commitment, but not independently.
TABLE 3. Work Stress, Personal Characteristics, and Metabolic and Hemostatic Factors (Mean Values of the Three Measurement
Days) As a Function of Imbalance Nested Under Overcommitment
Low Overcommitment High Overcommitment
Total
(N 5 124)Low Imbalance
(N 5 71)
High Imbalance
(N 5 13)
Low Imbalance
(N 5 25)
High Imbalance
(N 5 15)
Imbalance 0.63 6 0.14 1.19 6 0.19 0.72 6 0.13 1.24 6 0.27 0.78 6 0.29
Overcommitment 8.54 6 2.64 9.54 6 2.67 16.48 6 3.55 17.33 6 4.05 11.35 6 4.87
Age (years) 45.5 6 5.6 46.0 6 6.0 44.4 6 5.1 44.5 6 4.0 45.23 6 5.3
BMI (kg/m2) 24.8 6 2.7 24.8 6 2.2 25.6 6 3.2 25.9 6 2.7 25.1 6 2.8
Alcohol usea 2.0 6 1.0 1.8 6 1.1 2.2 6 1.3 2.0 6 0.9 1.98 6 1.02
Current smokers (%) 25.4 38.5 40.0 26.7 29.6
Educationa 5.0 6 1.4 4.9 6 1.9 4.8 6 1.9 5.2 6 1.5 5.0 6 1.4
Physical activitya 1.5 6 1.1 1.5 6 1.1 1.4 6 1.3 1.3 6 1.0 1.46 6 1.12
Years of service (years) 22.1 6 7.2 21.8 6 5.3 21.3 6 6.9 18.5 6 7.8 21.47 6 7.0
TC (mmol/liter) 5.50 6 0.95 5.47 6 1.20 5.42 6 0.90 5.81 6 1.02 5.52 6 0.97
TGs (mmol/liter)b 1.42 (0.62–8.13) 1.61 (0.63–5.05) 1.67 (0.55–4.10) 1.55 (0.65–3.97) 1.50 (0.55–8.13)
HDL/LDL ratio 3.23 6 1.19 3.35 6 1.30 3.62 6 1.43 3.85 6 1.83 3.40 6 1.35
Glucose (mmol/liter) 5.71 6 0.46 5.62 6 0.35 5.87 6 0.50 5.91 6 0.44 5.76 6 0.46
Insulin (mU/liter)b 6.21 (3.01–20.71) 6.44 (3.34–22.24) 7.60 (2.55–23.58) 6.92 (3.34–13.48) 6.57 (2.55–23.58)
PAI-1 (ng/ml)b 60.3 (10.5–247.9) 59.05 (15.7–120.9) 89.1 (30.3–190.7) 90.4 (27.9–273.3)c 68.2 (10.5–273.3)
tPA activity (IU/ml)b 0.59 (0.16–1.46) 0.61 (0.33–1.30) 0.47 (0.14–1.72) 0.37 (0.06–0.76)c 0.53 (0.06–1.72)
tPA antigen (ng/ml) 9.90 6 3.44 10.38 6 4.06 10.54 6 2.92 10.42 6 3.11 10.15 6 3.35
Fibrinogen (g/liter)b 2.96 (2.11–4.60) 2.94 (2.34–3.62) 2.97 (2.31–3.58) 2.75 (1.88–3.91) 2.93 (1.88–4.60)
a See Materials and Methods for explanation.
b Back-transformed logarithmic mean and range.
c Significantly different between high and low overcommitment groups (after correction for multiple testing according to Holm’s procedure).
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DISCUSSION
The aim of the study described here was to deter-
mine the effects of work stress on a cluster of metabolic
and hemostatic risk factors. Previous studies have pro-
vided evidence of short-term effects of acute stress on
several of these variables (6, 27, 28, 57, 58). However,
such small acute effects may be rapidly undone. For
instance, changes in tPA activity are almost instantly
compensated by circulating PAI-1 to maintain equilib-
rium (16, 59). Likewise, stress-induced release of free
fatty acids may be undone before cholesterol synthesis
(6). Only stressors of longer duration are likely to lead
to permanent changes in lipid metabolism and fibri-
nolysis. Chronic work stress was defined in this study
by effort-reward imbalance as well as overcommit-
ment, an exhaustive coping style. There is evidence
that either imbalance or overcommitment by itself or
the specific combination of the two components is
associated with an unfavorable cardiovascular risk
profile (2, 4, 33, 34). Because imbalance reflects high
work demand and because overcommitment might
cause incomplete unwinding after work, high work
stress may lead to an accumulation of work-related
fatigue toward the end of the work week. We, there-
fore, also explored an interaction of chronic work
stress with day of the week.
No evidence was found in any of the groups for a
cumulative work stress effect on any of the blood vari-
ables. Only glucose and TC showed a significant in-
traweek effect, but these effects did not reflect an ac-
cumulation of stress. The highest glucose levels were
found on Monday, and the highest TC levels were
found on Wednesday. This may reflect different eating
patterns or alcohol consumption on different week-
days or from work week to weekend. All risk factors
assessed in this study are, in fact, influenced by these
behavioral factors (12, 57, 60, 61). Thus, it is possible
that eating patterns or alcohol consumption somehow
masked intraweek changes. With this caveat in mind,
our results do not provide evidence for changes in
metabolic and hemostatic risk factors as a function of
weekday. This was independent of chronic work
stress; that is, no differential intraweek effects were
found in subjects with high imbalance or overcommit-
ment scores.
We found higher levels of PAI-1 than previous studies
that used comparable methods for PAI-1 analyses (19).
Because blood for PAI-1 analyses was collected on citrate
anticoagulation instead of on stabilyte, accidental leak-
age of PAI-1 from platelets could have inadvertently
raised PAI-1 levels. To test this, b-thromboglobulin, a
sensitive indicator of platelet contamination, was mea-
sured in 12 samples with the highest PAI-1 levels. The
median b-thromboglobulin value was 42 IU/ml (inter-
quartile range, 27–87 IU/ml), which is entirely within
acceptable values. Thus, high PAI-1 values were not due
to accidental increased leakage of PAI-1 from platelets.
We attribute the high PAI-1 values to circadian rhythm
effects (55). Blood sampling was always conducted in the
morning (between 8:00 and 9:30 AM) and reflects the
increase in PAI-1 seen during the latter part of the night.
Other studies, like that of Van der Bom et al. (19), sam-
pled throughout the day, which leads to lower values.
This suggested effect of time of sampling implies that
future studies should pay more attention to possible di-
urnal characteristics of PAI-1 antigen.
Neither imbalance nor overcommitment was related
to fibrinogen level in our subjects, which contrasts
with other studies (32, 33). However, a recently pub-
lished large cross-sectional study among 3427 Swed-
ish men and women also failed to confirm the relation
between work stress and fibrinogen (34). Fibrinogen
levels were not higher in men who reported a high
effort-reward ratio. Also, in a study by Mattiasson and
Lindgarde (35), occupational stress did not correlate
Fig. 1. All nine parameters as a function of effort-reward imbal-
ance and overcommitment. The risk scores were first stan-
dardized using normalized Z scores. The summed risk
score was computed as the sum of these nine Z scores using
the following formula: Zglucose 1 Zinsulin 1 ZTC 1 ZTG 1
Zfibrinogen 1 ZPAI-1 1 ZtPA antigen 2 ZtPA activity 2 ZHDL.
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with fibrinogen concentration, and men who reported
threatened job loss did not have higher fibrinogen
concentrations than other men. There is growing evi-
dence for the fact that social status, measured by em-
ployment grade, is inversely related to fibrinogen con-
centration (62, 63). If it is true that low-grade
employment is associated with more pronounced job
stress, then results from heterogeneous groups are dif-
ficult to interpret because job stress in part reflects
social class effects. Our study was conducted in a
homogeneous group of white-collar workers with low
variation in education level, an index of social class,
and our results did not show an effect of work stress on
fibrinogen levels. Thus, the current evidence suggests
that social class, more than work stress, influences
fibrinogen levels.
In the study described here, neither imbalance nor
imbalance-overcommitment interaction was associ-
ated with the IRS risk factors. This contrasts with
previous findings of an unfavorable lipid profile in
middle-aged men with high imbalance (33) and with
results of a study in which workers with high job
demands showed low tPA activity (37). Assessment of
imbalance in our study was based on a single measure-
ment. It did not take into account the duration of
imbalance, effort-reward in previous jobs, or possible
effects of periods of unemployment. These factors may
complicate the interpretation of our self-reported im-
balance measure (64). However, all of our subjects
were between 35 and 55 years of age, and the average
number of years of service in our study was 21.2 years,
meaning that most subjects developed their career at
the same computer company and had not been unem-
ployed for several years. Item analyses showed very
little variance in two of the three aspects of reward:
subjective experience of low status control (including
job instability) and low economic reward (income).
These aspects, however, largely determine intensity of
stressful experience and are the most important vari-
ables in predicting cardiovascular disease (1, 4, 47, 64).
Thus, in this homogenous white-collar population, ef-
fort-reward imbalance depended mainly on low es-
teem reward, which may explain why it was not asso-
ciated with risk profile.
In contrast to imbalance, overcommitment
showed a significant multivariate association with
the metabolic and hemostatic risk profile, as sum-
marized in Figure 1. In particular, overcommitment
was associated with an impaired fibrinolytic system,
as reflected in lower tPA activity and higher PAI-1.
Overcommitment has evolved from a critical analy-
sis of the global pattern of type A behavior and tells
something about the individual’s way of coping with
work demands. Individuals who score high on over-
commitment are competitive, impatient, have a high
need for approval, and are unable to “let go.” In the
long run, they are at risk for feelings of exhaustion
and physiological breakdown (50). Overcommitment
resembles the behavior style that is described to
precede the state of vital exhaustion (65). Vital ex-
haustion is a mood state that is characterized by
excess fatigue, a decrease in energy, and feelings of
helplessness or a sense of loss of control (37). Pro-
spective evidence shows it to be an independent
predictor of first myocardial infarction (65, 66). Two
recent studies showed a relation between vital ex-
haustion and deficient fibrinolysis. Kop et al. (39)
revealed significantly higher PAI-1 activity levels in
a well-defined group of exhausted subjects.
Ra¨ikko¨nen et al. (38) found that vital exhaustion was
related to elevated PAI-1 antigen. Our results are in
line with these observations but suggest that fibrino-
lytic impairment can be found already in the immer-
sive coping phase preceding vital exhaustion.
In previous studies on vital exhaustion, the relation
between vital exhaustion and PAI-1 disappeared after
correction for obesity, insulin, cholesterol, and TGs
(38, 39). Our study confirmed the pattern of significant
correlation between BMI and metabolic and fibrino-
lytic factors. The relationship between overcommit-
ment and fibrinolysis, however, remained intact after
correction for BMI, insulin, cholesterol, and TGs. The
pattern of correlations between obesity and metabolic
risk factors and deficient fibrinolysis has extensively
been reported before, and insulin resistance has been
assumed to be the underlying factor (11, 23, 25, 67). It
is attractive to summarize the currently available stud-
ies on overcommitment and the ensuing vital exhaus-
tion by hypothesizing that they affect insulin sensitiv-
ity and that this leads to secondary deficits in
metabolic and fibrinolytic factors. The exact neuroen-
docrine basis of this psychosomatic link remains to be
elucidated, but current evidence suggests that the pi-
tuitary-adrenocortical axis is implicated more than the
sympathetic-adrenal axis. The crucial aspect of vital
exhaustion and overcommitment is loss of control as-
sociated with a submissive, defeated reaction. This
type of reaction is characterized mainly by an increase
in cortisol secretion together with impaired produc-
tion of sex steroid hormones (68, 69). In addition,
cortisol has been strongly implied in the pathogenesis
of insulin resistance, possibly through direct effects on
insulin metabolism (48) or indirect effects on central
fat distribution (49, 69). Several studies corroborate
the idea that psychosocial stress affects insulin resis-
tance through activation of the hypothalamic-pitu-
itary-adrenal axis. Keltikangas-Ja¨rvinen et al. (70)
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showed that vital exhaustion was correlated with low
levels of adrenocorticotropic hormone and increased
levels of cortisol, insulin, and glucose. Nilsson et al.
(71) showed that free testosterone levels were de-
creased in subjects with high psychosocial stress who
also had higher plasma insulin levels.
In summary, our study points to impaired fibrino-
lysis in subjects scoring high on overcommitment.
High PAI-1 and low tPA activity, indicators of de-
creased fibrinolysis, contribute to persistence of fibrin
and subsequent thrombus formation. Thus, they present
a possible pathway for the often reported link between
subjective experience of work stress and atherosclero-
sis and cardiovascular disease.
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